CAC
Core Alternative Capital’s ResMed RMD Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $516 | Hold |
2
| – | – | ﹤0.01% | 314 |
|
|
2025
Q1 | $448 | Hold |
2
| – | – | ﹤0.01% | 316 |
|
|
2024
Q4 | $457 | Hold |
2
| – | – | ﹤0.01% | 335 |
|
|
2024
Q3 | $488 | Hold |
2
| – | – | ﹤0.01% | 336 |
|
|
2024
Q2 | $383 | Hold |
2
| – | – | ﹤0.01% | 344 |
|
|
2024
Q1 | $396 | Sell |
2
-40
| -95% | -$7.92K | ﹤0.01% | 337 |
|
|
2023
Q4 | $7.24K | Sell |
42
-2
| -5% | -$345 | ﹤0.01% | 336 |
|
|
2023
Q3 | $6.52K | Hold |
44
| – | – | ﹤0.01% | 360 |
|
|
2023
Q2 | $9.63K | Buy |
44
+4
| +10% | +$875 | ﹤0.01% | 319 |
|
|
2023
Q1 | $8.77K | Buy |
40
+2
| +5% | +$439 | ﹤0.01% | 330 |
|
|
2022
Q4 | $7.92K | Hold |
38
| – | – | ﹤0.01% | 316 |
|
|
2022
Q3 | $8K | Hold |
38
| – | – | ﹤0.01% | 318 |
|
|
2022
Q2 | $8K | Buy |
38
+12
| +46% | +$2.53K | ﹤0.01% | 320 |
|
|
2022
Q1 | $6K | Buy |
26
+21
| +420% | +$4.85K | ﹤0.01% | 337 |
|
|
2021
Q4 | $1K | Buy |
+5
| New | +$1K | ﹤0.01% | 407 |
|